End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.1 CNY | +2.99% | +2.99% | -7.46% |
04-25 | Harbin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-11 | Harbin Pharma to Upgrade Subsidiary's Production Base for 50 Million Yuan | MT |
Quotes 5-day view
End-of-day quote Shanghai S.E.2024-04-25 | 2024-04-26 | 2024-04-29 | 2024-04-30 | |
---|---|---|---|---|
Last | 2.83 ¥ | 3.01 ¥ | 3.01 ¥ | 3.1 ¥ |
Volume | 22 197 520 | 81 524 140 | 48 845 470 | 57 694 370 |
Change | +∞% | +6.36% | -.--% | +2.99% |
Opening | 2.82 | 2.90 | 3.01 | 3.00 |
High | 2.85 | 3.04 | 3.03 | 3.11 |
Low | 2.80 | 2.89 | 2.98 | 2.99 |
Performance
1 day | +2.99% | ||
1 week | +2.99% | ||
1 month | +2.31% | ||
3 months | +16.54% | ||
6 months | -13.41% | ||
Current year | -7.46% | ||
1 year | -4.91% | ||
3 years | +0.98% | ||
5 years | -35.01% | ||
10 years | -34.15% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Other Pharmaceuticals
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
+2.99% | +2.99% | -7.46% | -4.91% | 1.08B | ||
-2.58% | -4.06% | +21.85% | +51.46% | 546B | ||
-0.43% | +2.14% | -4.77% | -8.35% | 359B | ||
-0.58% | -2.80% | +16.97% | +7.87% | 323B | ||
+1.85% | +2.61% | +5.69% | +9.74% | 290B | ||
-0.87% | +0.52% | +13.68% | +1.40% | 234B | ||
-1.01% | -1.71% | +3.65% | -4.91% | 198B | ||
+1.49% | -1.67% | -11.12% | -22.70% | 194B | ||
+11.82% | +15.30% | +8.08% | +35.75% | 167B | ||
+0.40% | +9.49% | -3.40% | -27.67% | 157B | ||
-0.65% | +0.08% | +1.72% | -6.75% | 123B | ||
+0.66% | -1.92% | -14.27% | -33.99% | 89.17B | ||
+0.29% | +4.87% | +19.54% | +17.88% | 88.72B | ||
-0.84% | -0.98% | -20.03% | -18.46% | 80.78B | ||
+3.13% | +9.82% | +42.10% | +17.39% | 69B | ||
-.--% | +1.73% | - | - | 63.66B | ||
Average | +0.98% | +3.06% | +4.81% | +0.92% | ||
Weighted average by Cap. | +0.29% | +1.10% | +7.49% | +8.37% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | -7.46% | ||
2023 | +11.30% | ||
2022 | -15.21% | ||
2021 | +11.29% | ||
2020 | -15.83% | ||
2019 | -4.05% | ||
2018 | -32.01% | ||
2017 | -32.28% | ||
2016 | -6.50% | ||
2015 | +37.44% | ||
2014 | +41.60% | ||
2013 | -0.81% | ||
2012 | -15.69% | ||
2011 | -57.78% | ||
2010 | +22.20% | ||
2009 | +65.21% | ||
2008 | -32.85% | ||
2007 | +150.75% | ||
2006 | +38.62% | ||
2005 | -6.45% | ||
2004 | -45.71% | ||
2003 | -8.23% | ||
2002 | +92.85% | ||
2001 | -9.64% | ||
2000 | +73.58% | ||
1999 | +17.78% | ||
1998 | -4.39% | ||
1997 | +9.26% | ||
1996 | +177.23% | ||
1995 | -1.62% | ||
1994 | -3.75% |
- Stock Market
- Equities
- 600664 Stock
- Quotes Harbin Pharmaceutical Group Co., Ltd.